11/14/2024
7:42 AM | Esperion Therapeutics (Subject)
Two Seas Capital LP (Filed by)
| Form SC 13G/A | |
11/12/2024
1:23 PM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/07/2024
3:22 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:22 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:33 PM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
11:09 AM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G | |
|
10/18/2024
3:08 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
3:34 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
10/17/2024
2:25 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:11 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:12 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
2:20 PM | Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2024
2:28 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
3:33 PM | Esperion Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/12/2024
3:08 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
6:21 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
7:29 AM | Esperion Therapeutics (Issuer)
Foody Joanne M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
7:30 AM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
2:22 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
2:11 PM | Esperion Therapeutics (Subject)
Foody Joanne M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
7:03 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
3:16 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:20 PM | Esperion Therapeutics (Issuer)
Foody Joanne M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
2:09 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
2:19 PM | Esperion Therapeutics (Subject)
Foody Joanne M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
3:26 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
05/28/2024
3:16 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
2:08 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
7:50 AM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:29 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
3:21 PM | Esperion Therapeutics (Filer)
| Form DEF 14A | |
04/11/2024
3:19 PM | Esperion Therapeutics (Filer)
| Form ARS | |
03/15/2024
3:30 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:32 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:33 PM | Esperion Therapeutics (Issuer)
Looker Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:34 PM | Esperion Therapeutics (Issuer)
Foody Joanne M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:35 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
8:19 AM | Esperion Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
6:23 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:14 PM | CVI Investments, Inc. (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
Let’s be blunt (Ad) Let me be blunt with you for just a second…
You may think you know when and why stocks move, but you’re wrong…
Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight.
But once you’ve cracked this code…
It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!  Check out the $100 Challenge now |
02/14/2024
9:50 AM | Esperion Therapeutics (Subject)
Two Seas Capital LP (Filed by)
| Form SC 13G/A | |
02/14/2024
7:42 AM | Deep Track Capital, LP (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
5:11 AM | Esperion Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
01/24/2024
2:46 PM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024
2:21 PM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024
5:04 AM | Esperion Therapeutics (Filer)
| Form 424B5 | |
01/22/2024
5:10 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2024
4:01 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
01/11/2024
3:09 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
10:02 AM | Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
| Form SC 13G/A | |
01/03/2024
7:00 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
